Bioregenx (BRGX) Long-Term Deferred Tax (2023 - 2025)
Bioregenx (BRGX) posted quarterly Long-Term Deferred Tax of $1.4 million for Q4 2025, up 98.02% quarter-over-quarter from $707000.0 in Q4 2023.
Bioregenx (BRGX) Long-Term Deferred Tax (2023 - 2025) Analysis & Trends
Bioregenx's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, changed N/A from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $1.4 million, up from $707000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $1.4 million in Q4 2025, with the low at $707000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2023 | 707,000.00 |